Lucid Diagnostics LUCD is set to give its latest quarterly earnings report on Wednesday, 2025-05-14. Here's what investors need to know before the announcement.
Analysts estimate that Lucid Diagnostics will report an earnings per share (EPS) of $-0.11.
Investors in Lucid Diagnostics are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
Performance in Previous Earnings
The company's EPS missed by $0.04 in the last quarter, leading to a 3.33% increase in the share price on the following day.
Here's a look at Lucid Diagnostics's past performance and the resulting price change:
Quarter | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
EPS Estimate | -0.15 | -0.22 | -0.22 | -0.27 |
EPS Actual | -0.19 | -0.20 | -0.20 | -0.21 |
Price Change % | 3.0% | -4.0% | 2.0% | -2.0% |
Lucid Diagnostics Share Price Analysis
Shares of Lucid Diagnostics were trading at $1.1 as of May 12. Over the last 52-week period, shares are up 30.72%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.
To track all earnings releases for Lucid Diagnostics visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.